secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2026-06-16T20:30:35+00:00
Accession:  0001493152-26-028898
Event type: regulatory
Sentiment:  neutral
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions begins interference study for FDA 510(k) clearance of fingerprint drug test for codeine
--------------------------------------------------------------------------------

- Interference Study with 75 healthy adults to validate the system's codeine specificity against everyday substances.
- Expected completion by mid-July 2026; results will be part of the FDA 510(k) submission package.
- Study runs concurrently with Method Comparison Study; follows January 2026 Cut-off Study.
- Partners again with CenExel Clinical Research to conduct the clinical trial.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226028898/0001493152-26-028898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315226028898/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer